NL191978C - Reconstitueerbaar poeder en daarmee verkregen suspensie. - Google Patents

Reconstitueerbaar poeder en daarmee verkregen suspensie.

Info

Publication number
NL191978C
NL191978C NL8103902A NL8103902A NL191978C NL 191978 C NL191978 C NL 191978C NL 8103902 A NL8103902 A NL 8103902A NL 8103902 A NL8103902 A NL 8103902A NL 191978 C NL191978 C NL 191978C
Authority
NL
Netherlands
Prior art keywords
suspension
reconstitutable powder
reconstitutable
powder
Prior art date
Application number
NL8103902A
Other languages
English (en)
Dutch (nl)
Other versions
NL8103902A (nl
NL191978B (nl
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NL8103902A publication Critical patent/NL8103902A/nl
Publication of NL191978B publication Critical patent/NL191978B/xx
Application granted granted Critical
Publication of NL191978C publication Critical patent/NL191978C/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
NL8103902A 1980-08-22 1981-08-21 Reconstitueerbaar poeder en daarmee verkregen suspensie. NL191978C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18053780 1980-08-22
US06/180,537 US4321253A (en) 1980-08-22 1980-08-22 Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration

Publications (3)

Publication Number Publication Date
NL8103902A NL8103902A (nl) 1982-03-16
NL191978B NL191978B (nl) 1996-08-01
NL191978C true NL191978C (nl) 1996-12-03

Family

ID=22660812

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8103902A NL191978C (nl) 1980-08-22 1981-08-21 Reconstitueerbaar poeder en daarmee verkregen suspensie.

Country Status (41)

Country Link
US (1) US4321253A (es)
JP (1) JPS5775986A (es)
KR (1) KR860000513B1 (es)
AR (1) AR227201A1 (es)
AT (1) AT370994B (es)
AU (1) AU529965B2 (es)
BE (1) BE890028A (es)
BG (1) BG42000A3 (es)
CA (1) CA1137414A (es)
CH (1) CH650674A5 (es)
CS (1) CS225845B2 (es)
DD (1) DD201644A5 (es)
DE (1) DE3132614C2 (es)
DK (1) DK158971C (es)
DZ (1) DZ315A1 (es)
ES (1) ES504905A0 (es)
FI (1) FI72647C (es)
FR (1) FR2488798A1 (es)
GB (1) GB2082539B (es)
GR (1) GR74983B (es)
HK (1) HK43786A (es)
HU (1) HU188679B (es)
IE (1) IE51506B1 (es)
IL (1) IL63617A (es)
IN (1) IN156538B (es)
IT (1) IT1138161B (es)
KE (1) KE3626A (es)
LU (1) LU83572A1 (es)
MX (1) MX5731A (es)
MY (1) MY8600597A (es)
NL (1) NL191978C (es)
NO (1) NO154821C (es)
NZ (1) NZ198106A (es)
PH (1) PH17125A (es)
PL (1) PL232141A1 (es)
PT (1) PT73555B (es)
RO (1) RO82679B (es)
SE (1) SE448819B (es)
SU (1) SU1364226A3 (es)
YU (1) YU43985B (es)
ZA (1) ZA815793B (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE48715B1 (en) * 1978-12-22 1985-05-01 Elan Corp Plc New galencial forms for administration of medicaments by oral route,with programmed release and processes for preparing same
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
WO1984000004A1 (en) * 1982-06-14 1984-01-05 Key Pharma Sustained release aspirin
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
US4634587A (en) * 1982-07-09 1987-01-06 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
EP0113373B1 (en) * 1982-07-09 1991-08-28 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
AU569277B2 (en) * 1983-03-03 1988-01-28 Dow Chemical Company, The Aqueuos dispersion of water-insoluble organophilic cellulose ether for sustained release of active agents
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
SE8405611D0 (sv) * 1984-11-09 1984-11-09 Astra Laekemedel Ab Process for stabilization of bacampicillin hydrochloride
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
RU2123863C1 (ru) * 1992-04-30 1998-12-27 Шеринг Корпорейшн Содержащая гидратированный цефтибутен порошковая антибактериальная композиция, предназначенная для орального использования в виде суспензии
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
US6270804B1 (en) * 1998-04-03 2001-08-07 Biovail Technologies Ltd. Sachet formulations
IN191482B (es) * 1999-03-19 2003-12-06 Ranbaxy Lab Ltd
JP4711478B2 (ja) * 1999-08-13 2011-06-29 旭化成ケミカルズ株式会社 味がマスクされた薬物
US20050037086A1 (en) * 1999-11-19 2005-02-17 Zycos Inc., A Delaware Corporation Continuous-flow method for preparing microparticles
JP2003518485A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク 向上された薬物濃度を与える医薬組成物
EP1118333A1 (en) * 2000-01-18 2001-07-25 Eurand International S.P.A. Compositions with enhanced oral bioavailability
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
ATE361061T1 (de) 2000-04-20 2007-05-15 Novartis Ag Beschichtungszusammensetzung zur geschmacksmaskierung
AU2001268159B2 (en) * 2000-06-02 2005-09-15 Eisai Inc. Delivery systems for bioactive agents
FR2822834B1 (fr) * 2001-04-02 2005-02-25 Flamel Tech Sa Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
CA2447693A1 (en) * 2001-05-31 2002-12-05 Cima Labs Inc. Taste-masking of highly water-soluble drugs
KR20030015655A (ko) * 2001-08-17 2003-02-25 한미약품공업 주식회사 항암제의 경구흡수율을 증가시키는 인단계 화합물의결정성 산부가염, 이의 제조방법 및 이를 함유하는 약학적조성물
FR2830447B1 (fr) * 2001-10-09 2004-04-16 Flamel Tech Sa Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
ES2314227T7 (es) * 2002-04-09 2012-11-19 Flamel Technologies Formulacion farmaceutica oral en forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de amoxilicina.
ATE419840T1 (de) 2002-04-09 2009-01-15 Flamel Tech Sa Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
FR2842735B1 (fr) * 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
FR2843117B1 (fr) * 2002-07-30 2004-10-15 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
FR2860516B1 (fr) * 2003-10-03 2006-01-13 Flamel Tech Sa Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
FR2862536B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
US7244765B2 (en) * 2004-06-25 2007-07-17 Cytokine Pharmasciences, Inc Guanylhydrazone salts, compositions, processes of making and methods of using
FR2885526B1 (fr) * 2005-05-13 2007-07-27 Flamel Technologies Sa Medicament oral a base d'inhibiteur de pompe a protons
JP6184656B1 (ja) * 2015-10-13 2017-08-23 テクノガード株式会社 胃腸管粘膜保護組成物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549746A (en) * 1967-11-02 1970-12-22 Bristol Myers Co Antibiotic composition
US3873521A (en) * 1970-09-17 1975-03-25 Astra Laekemedel Ab Esters of {60 -amino penicillins
ZA718014B (en) 1970-12-23 1972-08-30 Beecham Group Ltd Pharmaceutical formulations
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
GB1455296A (en) * 1973-05-24 1976-11-10 Beecham Group Ltd Veterinary treatment
GB1479655A (en) 1974-03-08 1977-07-13 Beecham Group Ltd Antibiotic preparations
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
JPS5840529B2 (ja) * 1975-09-29 1983-09-06 明治製菓株式会社 ケイコウヨウセイザイノセイホウ
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
ZA793935B (en) * 1978-08-04 1980-07-30 Beecham Group Ltd Powders
JPS57105316A (en) * 1980-12-23 1982-06-30 Hitachi Cable Ltd Method of fitting heat-shrinkable tube

Also Published As

Publication number Publication date
DE3132614A1 (de) 1982-05-19
DK158971B (da) 1990-08-13
YU201781A (en) 1984-04-30
NL8103902A (nl) 1982-03-16
AU7441681A (en) 1982-04-01
PT73555B (en) 1983-07-14
YU43985B (en) 1990-02-28
GB2082539A (en) 1982-03-10
JPH0248525B2 (es) 1990-10-25
AT370994B (de) 1983-05-25
FI812574L (fi) 1982-02-23
SU1364226A3 (ru) 1987-12-30
PL232141A1 (es) 1982-03-15
BG42000A3 (en) 1987-09-15
IL63617A0 (en) 1981-11-30
FI72647C (fi) 1987-07-10
FR2488798B1 (es) 1985-01-11
IL63617A (en) 1984-11-30
BE890028A (fr) 1982-02-22
LU83572A1 (fr) 1982-04-14
IE51506B1 (en) 1987-01-07
US4321253A (en) 1982-03-23
SE448819B (sv) 1987-03-23
PT73555A (en) 1981-09-01
CH650674A5 (fr) 1985-08-15
IT1138161B (it) 1986-09-17
NO154821C (no) 1987-01-07
DK158971C (da) 1991-01-07
JPS5775986A (en) 1982-05-12
SE8104974L (sv) 1982-02-23
ES8303091A1 (es) 1983-02-01
ATA362781A (de) 1982-10-15
IE811911L (en) 1982-02-22
AR227201A1 (es) 1982-09-30
FR2488798A1 (fr) 1982-02-26
KR830005850A (ko) 1983-09-14
NL191978B (nl) 1996-08-01
FI72647B (fi) 1987-03-31
HU188679B (en) 1986-05-28
ES504905A0 (es) 1983-02-01
ZA815793B (en) 1982-08-25
CA1137414A (en) 1982-12-14
NZ198106A (en) 1983-12-16
MY8600597A (en) 1986-12-31
CS225845B2 (en) 1984-02-13
KE3626A (en) 1986-05-16
GB2082539B (en) 1984-01-18
MX5731A (es) 1993-11-01
PH17125A (en) 1984-06-01
DK372181A (da) 1982-02-23
RO82679A (ro) 1984-05-23
NO812827L (no) 1982-02-23
DD201644A5 (de) 1983-08-03
RO82679B (ro) 1984-07-30
IT8123587A0 (it) 1981-08-20
KR860000513B1 (ko) 1986-05-02
IN156538B (es) 1985-08-31
DE3132614C2 (de) 1985-08-22
DZ315A1 (fr) 2004-09-13
NO154821B (no) 1986-09-22
AU529965B2 (en) 1983-06-30
HK43786A (en) 1986-06-20
GR74983B (es) 1984-07-12

Similar Documents

Publication Publication Date Title
NL191978C (nl) Reconstitueerbaar poeder en daarmee verkregen suspensie.
DE3171325D1 (en) Tridecyloxy- or tetradecyloxy-propane derivatives, and their use
NO153996C (no) Pulverinhaleringsapparat.
MX9203117A (es) Benzotiofenos antiestrogenicos y antiandrogenicos.
FI822393A0 (fi) Pressvals, vars boejning aer instaellbar
FI841031A (fi) Absorberande material.
FI822164A0 (fi) Cylinderlaos-nyckelkombination, laoscylinder och nyckel foer denna kombination
FR2529756B1 (fr) Suspension s
FI843512L (fi) Projektil.
BE889227A (fr) Malette.
NO164798C (no) Utligningsventil- og stoetdemper- anordning.
RO82348A (ro) Valva rotativa
DE3381619D1 (de) Pendelvektor.
FI812707L (fi) Malningsanordning foer i suspension foereliggande materialfibrer foer pappersframstaellning
IT8119360A0 (it) 17alfa-acilossi-5beta-corticoidi e 17alfa-acilossi-5alfa-corticoidi.
DK228082A (da) Vandig kulsuspension
NO803713L (no) Bensement og anvendelse derav.
ES506267A0 (es) Perfeccionamientos en aparatos de electrorevestimento.
NO811867L (no) Selvlaasende opphengningsfeste.
IT8125692A0 (it) 5alfa-androstan-17beta-carbossilati e 5beta-androstan-17beta-carbossilati .
FI811971L (fi) Anordning foer avvattning av suspension
FI843157A0 (fi) Absorberande material av vegetabiliskt ursprung.
IT1136877B (it) Ammortizzatore
FI811797L (fi) Instravenoes medium
DK67581A (da) Sintrede termoluminescensdosimetre

Legal Events

Date Code Title Description
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20010821